JAK1 (oral)
Licensing pipeline · —
Licensing pipelineConfidentiality：Public
- INN / Generic Name
- JAK1 (oral)
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Others > Musculoskeletal & Orthopedics
- Indication
- Ankylosing spondylitis
- Current Status
- Candidate licensing (UB068)· Preclinical
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Licensing / co-development (by target & stage)
- MOQ
- 1 project
- Lead Time
- On request
- Price Range
- On request
HS Code
— Not a physical good (target / code name / technical service); no customs code applies.
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price